Antibiotice Iasi Eyes 6% Higher Revenue, Profit In 2016

04.20.2016 By Gabriela Stan

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) targets revenues of RON350 million and a gross profit of RON34.2 million in 2016, both 6% higher on the year, given negative factors such as the progressive increase of the clawback tax.

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

Keywords:
ANTIBIOTICE
, RESULTS
,

Please fill all required fields!

Your comment was successfully added!

Comments will appear only after the moderation.